University of Cincinnati Cancer Institute transplant surgeons are offering a unique procedure to remove inoperable, cancerous tumors from the bile duct of the liver, known
as cholangiocarcinoma, potentially improving survival...
Not exact matches
Incidences of intrahepatic
cholangiocarcinoma (ICC) are happening more often, with patients facing low chances of surviving the disease using current treatments - this can be
as low
as five per cent survival rate 12 months after diagnosis.
Studies show that curcumin inhibits different types of cancer such
as hepatocellular carcinoma and
cholangiocarcinoma by influencing these signalling proteins.